Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2713)
All Articles published online
|
Nov 7, 2006 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shin JW, Park NH, Jung SW, Kim BC, Kwon SH, Park JS, Jeong ID, Bang SJ, Kim DH. Clinical significance of hepatitis B e antigen level easurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive. World J Gastroenterol 2006; 12(41): 6693-6698 [PMID: 17075986 DOI: 10.3748/wjg.v12.i41.6693] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i41/6693.htm |
| Number | Citing Articles |
| 1 |
Darren J. Wong, Stephen A. Locarnini, Alexander J.V. Thompson. Clinical Virology. 2016; : 713 doi: 10.1128/9781555819439.ch32
|
| 2 |
Tin Nguyen, Paul Desmond, Stephen Locarnini. The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B. Hepatology International 2009; 3(S1): 5 doi: 10.1007/s12072-009-9149-7
|
| 3 |
Alicia Vachon, Carla Osiowy. Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management. Viruses 2021; 13(6): 951 doi: 10.3390/v13060951
|
| 4 |
Lorenzo Piermatteo, Mohammad Alkhatib, Stefano D’Anna, Vincenzo Malagnino, Ada Bertoli, Eleonora Andreassi, Elisa Basile, Alessandra Iuvara, Maria De Cristofaro, Giuseppina Cappiello, Carlotta Cerva, Carmine Minichini, Mariantonietta Pisaturo, Mario Starace, Nicola Coppola, Carla Fontana, Sandro Grelli, Francesca Ceccherini-Silberstein, Massimo Andreoni, Upkar S. Gill, Patrick T. F. Kennedy, Loredana Sarmati, Romina Salpini, Valentina Svicher. HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation. Biomedicines 2021; 9(10): 1352 doi: 10.3390/biomedicines9101352
|
| 5 |
D. Scott Bowden, Alex J. Thompson. New developments in HBV molecular diagnostics and quantitative serology. Hepatology International 2008; 2(S1): 3 doi: 10.1007/s12072-008-9051-8
|
| 6 |
Johannes Vermehren, Annika Kau, Stefan Zeuzem. Baseline and On-Treatment Predictors for Outcome of Chronic Hepatitis B Treatment. Current Hepatitis Reports 2010; 9(2): 53 doi: 10.1007/s11901-010-0036-4
|
| 7 |
Yi‐Hao Yen, Sheng‐Nan Lu, Chien‐Hung Chen, Jing‐Houng Wang, Chun‐Mei Wu, Chao‐Hung Hung, Po‐lin Tseng, Tsung‐Hui Hu, Chi‐Sin Changchien, Chuan‐Mo Lee. Changes in serum hepatitis B e antigen (HBeAg) levels associated with the emergence of YMDD mutants in HBeAg non‐seroconverted patients during lamivudine therapy. Liver International 2007; 27(10): 1349 doi: 10.1111/j.1478-3231.2007.01609.x
|
| 8 |
Sarah Maylin, Anders Boyd, Fabien Lavocat, Joel Gozlan, Caroline Lascoux-Combe, Patrick Miailhes, Ludovic Lassel, Constance Delaugerre, Pierre-Marie Girard, Fabien Zoulim, Karine Lacombe. Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV–hepatitis B virus-infected patients. AIDS 2012; 26(8): 939 doi: 10.1097/QAD.0b013e328352224d
|
| 9 |
Sarah Maylin, Anders Boyd, Michelle Martinot-Peignoux, Constance Delaugerre, Georges Bagnard, Martine Lapalus, Fabien Zoulim, Fabien Lavocat, Patrick Marcellin, François Simon, Pierre-Marie Girard, Karine Lacombe. Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus. Journal of Clinical Virology 2013; 56(4): 306 doi: 10.1016/j.jcv.2012.12.022
|
| 10 |
Robério Amorim de Almeida Pondé. Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach. Molecular Biology Reports 2021; 48(1): 843 doi: 10.1007/s11033-020-06056-4
|
| 11 |
K. Wursthorn, B. J. Zacher, J. Jaroszewicz, M. Darnedde, M. Manns, H. Wedemeyer. Development of a protocol for the quantitative determination of HBeAg using the Elecsys® HBeAg immunoassay. Journal of Viral Hepatitis 2011; 18(7) doi: 10.1111/j.1365-2893.2010.01419.x
|